Search Results 291-300 of 14823 for anti-TNF drugs

  1. Triamcinolone (Injection Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aristocort; Aristocort Forte; Aristospan; Clinacort ...

  2. Ixekizumab (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Ixekizumab injection is used to treat moderate-to-severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

  3. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

    ustekinumab mono or combination therapy;; patients on mesalamine or no therapy. Group B (Low vaccine responders):. Anti-TNF monotherapy;; anti-TNF combination ...

  4. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

    Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary ...

  5. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...

  6. Emerging treatments for multiple sclerosis - Mayo Clinic

    The majority of DMTs approved by the U.S. Food and Drug Administration (FDA) are effective at helping to manage relapsing-remitting MS. This form of MS affects ...

  7. Tocilizumab-Aazg (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Tocilizumab-aazg injection is used alone or together with other medicines to treat moderate to severe active rheumatoid arthritis in patients who have been ...

  8. Measles - Diagnosis & treatment - Mayo Clinic

    Medications. Treatment for a measles infection may include: Fever reducers. If a fever is making you or your child uncomfortable, you can use ...

  9. Neuromyelitis optica: New therapies offer hope - Mayo Clinic

    The Food and Drug Administration (FDA) has approved the use of three medications for the treatment of neuromyelitis optica spectrum disorder (NMOSD).

  10. Science Saturday: Researchers explore personalized approach to anti-obesity medications

    Acosta and a team of Mayo Clinic researchers set out to study anti-obesity medications based on obesity phenotypes to enhance weight loss. A phenotype is a set ...